Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for CVRx, Inc. (CVRX : NSDQ)

• Company Description    CVRx Inc. is a commercial-stage medical device company. It focused on developing, manufacturing and commercializing neuromodulation solutions for patients with cardiovascular diseases. CVRx Inc. is headquartered in Minneapolis, MN. Number of Employees: 109

• Price / Volume Information    Yesterday's Closing Price: $5.25 Daily Weekly Monthly 20 Day Moving Average: 206,710 shares Shares Outstanding: 20.50 (millions) Market Capitalization: $107.63 (millions) Beta: 52 Week High: $29.00 52 Week Low: $4.60 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 7.36% 20.91% 12 Week -39.24% -33.20% Year To Date -57.07% -49.55%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 9201 WEST BROADWAY AVENUE SUITE 650 - MINNEAPOLIS,MN 55445 USA ph: 763-416-2840 fax: 763-416-2841 ir@cvrx.com http://www.cvrx.com

• General Corporate Information    Officers Nadim Yared - Chief Executive Officer and President Jared Oasheim - Chief Financial Officer Ali Behbahani - Director John Nehra - Director Geoff Pardo - Director Peer Information CVRx, Inc. (ABMD) CVRx, Inc. (DMDS) CVRx, Inc. (CPWY.) CVRx, Inc. (EQUR) CVRx, Inc. (ECIA) CVRx, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 126638105 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/03/22 Share - Related Items Shares Outstanding: 20.50 Most Recent Split Date: (:1) Beta: Market Capitalization: $107.63 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.54 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-2.14 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/03/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.79 Price/Cash Flow: - Price / Sales: 7.55 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: 5.77% Sales Growth vs. Year Ago Period: 42.52% vs. Previous Quarter: 11.43% ROE 03/31/22 - -148.64 12/31/21 - - 09/30/21 - - ROA 03/31/22 - -33.31 12/31/21 - -44.26 09/30/21 - - Current Ratio 03/31/22 - 21.57 12/31/21 - 25.58 09/30/21 - 20.42 Quick Ratio 03/31/22 - 20.77 12/31/21 - 24.92 09/30/21 - 20.03 Operating Margin 03/31/22 - -311.83 12/31/21 - -330.45 09/30/21 - - Net Margin 03/31/22 - -311.83 12/31/21 - -330.45 09/30/21 - - Pre-Tax Margin 03/31/22 - -311.13 12/31/21 - -329.76 09/30/21 - - Book Value 03/31/22 - 6.67 12/31/21 - 7.17 09/30/21 - 7.66 Inventory Turnover 03/31/22 - 0.95 12/31/21 - 1.39 09/30/21 - - Debt-to-Equity 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.10 Debt-to-Capital 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 9.39

Powered by Zacks Investment Research ©